Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

Todd Neale

October 09, 2020

News Daily News

“所有患者”研究表明完全血运重建能改善有或无糖尿病患者的生存率

Caitlin E. Cox

May 08, 2015

News Daily News

‘All-Comers’ Study Shows Survival Benefit of Complete Revascularization in Patients With, Without Diabetes

Caitlin E. Cox

May 08, 2015

News Daily News

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

L.A. McKeown

April 11, 2014

News Daily News

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

L.A. McKeown

April 11, 2014

News Daily News

Meta-analysis Confirms Mortality Edge with CABG over PCI in Diabetic Patients

L.A. McKeown

September 20, 2013

News Daily News

Los Balones liberadores de Fármacos Reducen la RLD en Diabéticos con Isquemia Crítica de las Extremidades

Jason Kahn

July 05, 2013

News Daily News

Drug-Eluting Balloons Lower TLR in Diabetics with Critical Limb Ischemia

Jason Kahn

July 05, 2013

News Daily News

La Colchicina Reduce la Reestenosis de los SMD en Pacientes Diabéticos

April 19, 2013

News Daily News

Colchicine Reduces BMS Restenosis in Diabetic Patients

April 19, 2013

News Daily News

PCI, Surgery Show Similar Long-term Mortality in Diabetic, Nondiabetic Patients

L.A. McKeown

August 15, 2012

News Daily News

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

Jason Kahn

July 18, 2011

News Daily News

Pioglitazone Can Decrease Need for Revascularization in Diabetic Patients After BMS

L.A. McKeown

April 07, 2011

News Daily News

Study Compares Stents, Surgery in Diabetics with Multivessel Disease

Caitlin E. Cox

March 23, 2011

News Daily News

Studies Support DES Use in Diabetics, But Results Vary by Device

Caitlin E. Cox

March 08, 2011

Advertisement

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

“所有患者”研究表明完全血运重建能改善有或无糖尿病患者的生存率

‘All-Comers’ Study Shows Survival Benefit of Complete Revascularization in Patients With, Without Diabetes

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

Meta-analysis Confirms Mortality Edge with CABG over PCI in Diabetic Patients

Los Balones liberadores de Fármacos Reducen la RLD en Diabéticos con Isquemia Crítica de las Extremidades

Drug-Eluting Balloons Lower TLR in Diabetics with Critical Limb Ischemia

La Colchicina Reduce la Reestenosis de los SMD en Pacientes Diabéticos

Colchicine Reduces BMS Restenosis in Diabetic Patients

PCI, Surgery Show Similar Long-term Mortality in Diabetic, Nondiabetic Patients

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

Pioglitazone Can Decrease Need for Revascularization in Diabetic Patients After BMS

Study Compares Stents, Surgery in Diabetics with Multivessel Disease

Studies Support DES Use in Diabetics, But Results Vary by Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content